EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Preliminary evaluation of qualitative RT-PCR and indirect immunofluorescence for SARS-CoV-2 detection in nasopharyngeal swabs samples

Luis G. Medina-Pestana, Nathaly A. Mayora-Hernández, Ivis Luisana-Camejo, Benito Aguilera, Víctor Picos, Elizabeth Ferrer, Daria E. Camacho-García

Microbes, Infection and Chemotherapy · 2026-11-04 · 6 · e2873

DOI: 10.54034/mic.e2873 ↗
AbstractBibliografische Angaben

Abstract

Introduction: The COVID-19 pandemic made it essential to expand SARS-CoV-2 diagnostic capacity. Two laboratory techniques—qualitative RT-PCR and indirect immunofluorescence (IIF)—were preliminarily evaluated for virus detection in nasopharyngeal samples. Methods: RNA extracted from nasopharyngeal swabs of patients with infection confirmed by RT-qPCR was used to establish the amplification conditions for a 128-bp fragment of the SARS-CoV-2 N gene by RT-PCR. Under the selected conditions, 65 samples from patients with clinical manifestations compatible with COVID-19 were analyzed. For IIF, a purified preparation of anti-SARS-CoV-2 IgG antibodies obtained from positive serum samples previously analyzed with a commercial ELISA was used. The antibodies bound to viral antigens in cells from nasopharyngeal swabs and were detected with a fluorescein isothiocyanate-conjugated anti-human IgG antibody. Results: The selected conditions for amplification of the 128-bp fragment were 1.5 mM MgCl₂, 0.6 µM of each primer, 0.2 mM dNTPs, 5.0 U of Taq polymerase and 5.0 U of reverse transcriptase, and an annealing temperature of 57 °C. Under these conditions, 64 of 65 samples (98.46%) yielded the expected amplicon. IIF revealed fluorescence-positive cells and showed no reactivity against the evaluated panel of other viruses. Conclusion: Qualitative RT-PCR and IIF showed favorable preliminary results for SARS-CoV-2 detection in nasopharyngeal samples. A complete analytical and clinical evaluation is required before either technique can be considered for diagnostic use.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →